What Does Bicara Therapeutics CEO Sale Signal Investors
When a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
Analysis of entities with the lowest risk in crypto, plus how to interpret liquidity, use case maturity, and developer activity for safer bets.
28,397 articlesWhen a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
A rising chorus of planners argues the fixed 4% rule may trap retirees in unnecessary caution. Experts say flexible w...
A tech-heavy portfolio is getting a diversification push as AVUV draws new attention among 38-year-olds with $500k sa...
Blue Origin plans a $10 billion round at a $130 billion valuation, backed by Jeff Bezos and institutional investors. ...
A $28 billion AI hardware IPO is trading at about 7x forward earnings, sparking a heated debate: is it a disrupted, d...
Caterpillar has emerged as a heavyweight in the Dow, powered by AI-driven infrastructure demand and mining activity. ...
Tariff policy volatility follows a high court ruling, and a new AI platform aims to help firms weather the disruption...
A fiery address from Palantir’s CEO has ignited a broader debate on how AI firms partner with the Pentagon and how po...
Federal OSHA has opened a federal review of Nevada’s workplace safety agency after three willful citations against El...
Nike has faced a tough run, but a turnaround could be on the horizon. This guide breaks down the factors to watch, re...
Investors are shifting bets toward defense names as urban warfare tech dominates modernization plans. This piece exam...
Inflation soaring again, this under-the-radar ETF is quietly drawing interest from investors seeking an edge against ...